Novartis investors seek tighter focus on M&A after setbacks
Reuters reports Novartis shareholders plan to scrutinize the company’s dealmaking strategy after setbacks to drugs acquired via M&A affected its shares.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.